相关实验视频
Updated: May 31, 2025

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
40.1K
吸入会加剧呼吸道过敏反应,通过在OVA诱导的过敏喘中提高PNEC来源的5-HT的调节
Xue Lu1, Zhu-Xia Tan2, Ya-Xin Yao2
1Department of Toxicology, Anhui Medical University, Hefei, China.
Ecotoxicology and environmental safety
|January 24, 2025
概括
环境 (As) 暴露会在过敏性喘中恶化呼吸道过敏反应. 这种效应与肺部增加的血清素 (5-HT) 生产有关,这表明喘治疗的新目标.
科学领域:
- 环境健康 环境健康
- 毒理学 毒理学 毒理学
- 免疫学 免疫学 免疫学
背景情况:
- 儿童喘是一个日益严重的公共卫生问题.
- 流行病学研究将生命早期接触无机 (As) 与喘风险增加联系起来.
- 呼吸系统A暴露对过敏喘发展和严重程度的具体影响尚不清楚.
研究的目的:
- 在小鼠模型中研究呼吸道暴露对过敏喘的影响.
- 探索潜在的机制,特别是血清素 (5-HT) 和肺神经内分泌细胞 (PNEC) 的作用.
主要方法:
- BALB/c小鼠通过吸入暴露于酸 (NaAsO2) 气溶或水中.
- 过敏性喘:小鼠被敏感化并用卵胺 (OVA) 挑战诱导过敏性喘.
- 评估了气道过敏反应,炎症标志物,细胞因子水平和5-HT通路.
- 一种基酶 (TPH) 抑制剂 (LX1032) 用于研究5-HT的作用.
主要成果:
- 对的暴露并没有使喘小鼠的杯状细胞过度增生或粘液分泌恶化.
- 炎症细胞透和Th2细胞因子水平 (IL-4,IL-5,IL-13) 没有因暴露而恶化.
- 对的暴露显著加剧了喘小鼠的呼吸道过敏反应.
- 暴露加剧了OVA诱导的5-HT及其合成酶 (TPH1,TPH2) 在肺中的升高.
- 用LX1032抑制TPH降低了5-HT水平,并缓解了引起的气道过敏反应.
结论:
- 在过敏喘的小鼠模型中,呼吸道暴露会加剧气道过敏反应.
- 这种效应部分由肺5-HT的上调调节介导,可能来自PNEC.
- 向5-HT途径为缓解引起的喘恶化提供了潜在的治疗策略.
相关概念视频
Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Anticholinesterase Agents: Poisoning and Treatment
779
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
779
Chemical Factors Affecting Respiration Centers
1.0K
Chemical factors such as changing CO2, O2, and H+ levels in arterial blood play a critical role in influencing respiration depth and rates. These variations are detected by chemoreceptors—specialized sensors located in two primary body areas. Central chemoreceptors are found throughout the brain stem, including the ventrolateral medulla, while peripheral chemoreceptors are located in the aortic arch and carotid arteries.
CO2 has a potent influence on respiration and is strictly regulated....
CO2 has a potent influence on respiration and is strictly regulated....
1.0K

